# Head and Neck Advanced Research for Multi-Omics and Optimized Immunotherapy

> **NCT07211139** · — · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07211139
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-08
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211139, "Head and Neck Advanced Research for Multi-Omics and Optimized Immunotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07211139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*